office delivery sina specify cell popup vivo remain formed challenge success therapeutic applied describe novel sirnabas approach synthetic link oligonucleotid tr agonist target silent gene myeloid cell b key common tumor microenviron stat tumorassoci immune suppress antitumor response hinder tlrinduc stimuli test cpgstatsirna concur effect inject local site system intranet rout access dendritic macrophages inhibit express lead active ultima potent find demons potent agonistsirna target gene silent couple 